Advisor Group Holdings, Inc. Finch Therapeutics Group, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.36 - $56.4 $284 - $44,556	-790 Reduced 76.03%	249 $0
Q3 2022 Nov 14, 2022	BUY	$1.75 - $51.3 $192 - $5,643	110 Added 11.84%	1,039 $2,000
Q2 2022 Aug 10, 2022	BUY	$1.91 - $5.11 $1,696 - $4,537	888 Added 2165.85%	929 $3,000
Q1 2022 May 04, 2022	BUY	$5.02 - $10.47 $150 - $314	30 Added 272.73%	41 $41,000
Q3 2021 Nov 05, 2021	BUY	$12.2 - $16.75 $61 - $83	5 Added 83.33%	11 $0
Q2 2021 Aug 02, 2021	BUY	$12.03 - $17.51 $72 - $105	6 New	6 $0

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $563M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.